These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29403994)

  • 1. Development of a physiologically relevant dripping analytical method using simulated nasal mucus for nasal spray formulation analysis.
    Masiuk T; Kadakia P; Wang Z
    J Pharm Anal; 2016 Oct; 6(5):283-291. PubMed ID: 29403994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design.
    Guo C; Stine KJ; Kauffman JF; Doub WH
    Eur J Pharm Sci; 2008 Dec; 35(5):417-26. PubMed ID: 18832029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
    Dayal P; Shaik MS; Singh M
    J Pharm Sci; 2004 Jul; 93(7):1725-42. PubMed ID: 15176062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical challenges and regulatory requirements for nasal drug products in europe and the u.s.
    Trows S; Wuchner K; Spycher R; Steckel H
    Pharmaceutics; 2014 Apr; 6(2):195-219. PubMed ID: 24732068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast nasal spray: formulation development and in vitro evaluation.
    Jullaphant T; Nakpeng T; Srichana T
    Pharm Dev Technol; 2019 Apr; 24(4):494-503. PubMed ID: 30124348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of experiments to optimize an in vitro cast to predict human nasal drug deposition.
    Shah SA; Dickens CJ; Ward DJ; Banaszek AA; George C; Horodnik W
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):21-9. PubMed ID: 23461532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
    Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
    Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
    Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
    Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity.
    Inoue D; Yamashita A; To H
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow.
    Moraga-Espinoza D; Warnken Z; Moore A; Williams RO; Smyth HDC
    Int J Pharm; 2018 Sep; 548(1):305-313. PubMed ID: 29960037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders.
    Gholizadeh H; Cheng S; Pozzoli M; Messerotti E; Traini D; Young P; Kourmatzis A; Ong HX
    Expert Opin Drug Deliv; 2019 Apr; 16(4):453-466. PubMed ID: 30884987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical Challenges of Spray Pattern Method Development for Purposes of
    Grmaš J; Dreu R; Injac R
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):200-212. PubMed ID: 30964389
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of actuation parameters on in vitro testing of nasal spray products.
    Guo C; Doub WH
    J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in the formulation and delivery of spray dried vaccines.
    Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
    Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis.
    Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
    Int J Pharm; 2018 Jan; 535(1-2):113-119. PubMed ID: 29038066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
    Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
    Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT; Baker RC
    Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneously compounded amiloride nasal spray.
    Yellepeddi V; Sayre C; Burrows A; Watt K; Davies S; Strauss J; Battaglia M
    PLoS One; 2020; 15(7):e0232435. PubMed ID: 32649677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.